C. Robert Cory

No más puestos en curso

Health Technology

Consumer Services

Perfil

Dr. C.
R.
Cory is Global Head-Business Development at biOasis Technologies, Inc. Dr. Cory was previously employed as Vice President-Business Development by MIGENIX, Inc. He received his MBA from Wilfrid Laurier University and a doctorate degree from The University of Waterloo.

Antiguos cargos conocidos de C. Robert Cory.

Empresas	Cargo	Fin
MIGENIX, Inc. MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.	Corporate Officer/Principal	24/03/2010
BIOASIS TECHNOLOGIES INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de C. Robert Cory.

Formación de C. Robert Cory.

The University of Waterloo	Doctorate Degree
Wilfrid Laurier University	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de C. Robert Cory.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
BIOASIS TECHNOLOGIES INC.	Health Technology

Empresas privadas	1
MIGENIX, Inc. MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.	Health Technology